survival
The addition of brentuximab vedotin improved survival in Hodgkin lymphoma.
A new model that makes use of a promising imaging biomarker can predict diffuse large B-cell lymphoma relapse and survival ...
The expression patterns and clinical significances of CD300s in cancers are still not well understood.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.